Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Critical Reviews in Oncology/Hematology|July 7, 2019
Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemiaTaylor M Weis, Bernard L Marini, Dale L Bixby, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 15, 2016
Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemiaBeejal R Ganti, Bernard L Marini, Jerod Nagel, et al.
Blood Reviews|July 13, 2017
Catalyzing improvements in ALL therapy with asparaginaseBernard L Marini, Anthony J Perissinotti, Dale L Bixby, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 4, 2022
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged NeutropeniaWilliam Alegria, Bernard L Marini, Kevin Sellery Gregg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 11, 2015
Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropeniaBernard L Marini, Shannon M Hough, Kevin S Gregg, et al.
Leukemia Research|November 6, 2017
Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessmentVictoria R Nachar, Anthony J Perissinotti, Gianni B Scappaticci, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 2, 2018
Successful use of cytarabine and bendamustine in a patient with mantle cell lymphoma and acute renal failure using intermittent hemodialysis: A case reportMatthew Ettleson, Kale S Bongers, Kaitlyn Vitale, et al.
The Journal of Antimicrobial Chemotherapy|February 11, 2017
Risk factors and impact of Clostridium difficile recurrence on haematology patientsGianni B Scappaticci, Anthony J Perissinotti, Jerod L Nagel, et al.
Critical Reviews in Oncology/Hematology|February 29, 2020
Contemporary treatment options for a classical disease: Advanced Hodgkin lymphomaJustin H Reid, Bernard L Marini, Victoria R Nachar, et al.
Pageof 7